日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG

关于脂肪胰的定义、诊断标准和治疗的国际多学科共识报告:由欧洲胰腺癌协会 (EPC)、美国胰腺病学会 (APA)、欧洲糖尿病研究协会 (EASD)、欧洲肝脏研究协会 (EASL)、欧洲胃肠病学会 (ESGAR)、欧洲胃肠内镜学会 (ESGE)、欧洲胰腺外科学会 (ESP)、欧洲胃肠病学和胃肠病学会 (ESPCG)、欧洲肠外肠内营养学会 (ESPEN)、欧洲儿科胃肠病学、肝病学和营养学会 (ESPGHAN)、国际儿科学会 (IAP)、日本胰腺外科学会 (JPS)、韩国胰腺和胆管癌协会 (KPBA)、洛杉矶胰腺外科和胃肠病学研究组 (LAPSG) 以及欧洲胃肠病学和胃肠病学学会 (UEG) 联合认可的声明。

Vujasinovic, Miroslav; Demir, Ihsan Ekin; Marchegiani, Giovanni; Hegyi, Peter; Archibugi, Livia; Valente, Roberto; Capurso, Gabriele; Witt, Heiko; Bonovas, Stefanos; Piovani, Daniele; Rosendahl, Jonas; Maisonneuve, Patrick; Verbeke, Caroline S; Karçaaltıncaba, Muşturay; Dominguez-Muñoz, J Enrique; Scheers, Isabelle; Czako, Laszlo; Wagner, Robert; Rebours, Vinciane; Öhlund, Daniel; Idilman, Ilkay S; Overbeek, Kasper; Gubergrits, Natalya; Engjom, Trond; Neesse, Albrecht; Apte, Minoti; Bezmarević, Mihailo; Braren, Rickmer; Bunduc, Stefania; Ceyhan, Güralp Onur; Chouhan, Manil Dinesh; Couvelard, Anne; Cros, Jérôme; Iglesia, Daniel de la; de-Madaria, Enrique; Drenth, Joost P H; Drewes, Asbjørn Mohr; Sarasqueta, Arantza Fariña; Fracasso, Pierluigi; Francque, Sven; Frøkjær, Jens Brøndum; Iglesias-Garcia, Julio; Garg, Pramod; Gerst, Felicia; Gulbinas, Antanas; Gürcinar, Ibrahim Halil; Heni, Martin; Hyun, Jong Jin; Jonas, Eduard; Kiriukova, Mariia; Kitano, Masayuki; Krag, Aleksander; Laukkarinen, Johanna; Lipp, Mónika; Lovecek, Martin; Martignoni, Marc; Masip, Etna; Matsumoto, Ryotaro; Molven, Anders; Mozhyna, Tetiana; Nosakova, Lenka; Obmann, Verena; Ockenga, Johann; Pandanaboyana, Sanjay; Panić, Nikola; Papachristou, Georgios; Pasqua, Analia Verónica; Pawlak, Katarzyna M; Pelaez-Luna, Mario; Regel, Ivonne; Regnér, Sara; Robinson, Stuart; Seicean, Andrada; Singh, Vijay; Smits, Mark M; Sung, Min Je; Tacelli, Matteo; Taylor, Roy; Teutsch, Brigitta; Udrescu, Mihaela; Wilschanski, Michael; Yavas, Aslihan; Zamboni, Giulia A; Löhr, J Matthias

Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial

恩格列净、氯沙坦及其联合用药在2型糖尿病患者中降低血压的机制:一项随机交叉试验的二次分析

Scholtes, Rosalie A; Mosterd, Charlotte M; Hesp, Anne C; Smits, Mark M; Heerspink, Hiddo J L; van Raalte, Daniël H

Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial

二肽基肽酶-4抑制剂利格列汀与磺脲类药物格列美脲对2型糖尿病成人患者餐后肾脏血流动力学影响的比较(RENALIS):一项随机、双盲试验的预设子研究

Muskiet, Marcel H A; Tonneijck, Lennart; Smits, Mark M; Kramer, Mark H H; Ouwens, D Margriet; Hartmann, Bolette; Holst, Jens J; Danser, A H Jan; Joles, Jaap A; van Raalte, Daniël H

Safety of Semaglutide

索马鲁肽的安全性

Smits, Mark M; Van Raalte, Daniël H

Corrigendum: Safety of Semaglutide

更正:司美格鲁肽的安全性

Smits, Mark M; Van Raalte, Daniël H

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross-sectional study

2型糖尿病超重患者皮肤微血管功能和肾脏血流动力学:一项横断面研究

Bouman, Emma J; Smits, Mark M; van Bommel, Erik J; Muskiet, Marcel H A; Hesp, Anne C; Serné, Erik H; Joles, Jaap A; van Raalte, Daniël H

Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands

荷兰 COVID-PREDICT 队列研究的数据显示,在因 COVID-19 入院时接受 DPP-4 抑制剂治疗与改善临床结局无关。

Meijer, Rick I; Hoekstra, Trynke; van den Oever, Niels C Gritters; Simsek, Suat; van den Bergh, Joop P; Douma, Renée A; Reidinga, Auke C; Moeniralam, Hazra S; Dormans, Tom; Smits, Mark M

Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial

二肽基肽酶-4抑制剂利格列汀与磺脲类药物格列美脲对超重2型糖尿病患者全身血液动力学的影响:一项为期8周的随机、对照、双盲试验的二次分析

Kraaijenhof, Jordan; Muskiet, Marcel H A; Tonneijck, Lennart; Ouwens, D Margriet; Kramer, Mark H H; van Raalte, Daniël H; Smits, Mark M

Plasma uric acid and renal haemodynamics in type 2 diabetes patients.

2 型糖尿病患者的血浆尿酸和肾脏血流动力学

Suijk Danii Ls, Smits Mark M, Muskiet Marcel Ha, Tonneijck Lennart, Kramer Mark Hh, Joles Jaap A, van Raalte Daniël H

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials

立即和长期给予GLP-1受体激动剂对尿酸和肾脏清除率的影响:四项临床试验的事后分析

Tonneijck, Lennart; Muskiet, Marcel H A; Smits, Mark M; Bjornstad, Petter; Kramer, Mark H H; Diamant, Michaela; Hoorn, Ewout J; Joles, Jaap A; van Raalte, Daniël H